75N98024A00061 - O/M ITEMS ONLY: BIOLOGICAL MATERIALS, CHEMICALS, ...

This BPA contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2024 on Jan 30, 2024 to NEW ENGLAND BIOLABS, INC. by NIH Office of Logistics and Acquisition Operations (OLAO). There have been $68.7k in obligations to date with a ceiling value of $10M, showing a 1% burn rate so far on the contract. The contract was not competed under any preference program with offers received. We expect a 1 year duration with ultimate completion date of Jan 30, 2025.

NEW ENGLAND BIOLABS, INC. is a contractor located in MA, doing primarily Pharmaceuticals > Pharmaceutical Products work for Health and Human Services. The company receives $199.5k annually in federal awards (as of FY2020). Also, they have shown success winning No/Limited Bias contracts concentrated mainly on a singular customer focused portfolio.

Blanket Purchase Agreements or BPAs establish a method for the Government to satisfy a repetitive need for goods and services. When a government-wide need exists for specific products or services, a BPA allows the Government to establish a single contract to satisfy those needs. Creating a single source for common needs enables the Government to use buying power to drive down prices and avoid the higher costs associated with hundreds or thousands of customers purchasing independently.

Read the full report

Buying Agency/Office

Health and Human Services»National Institutes of Health»NIH Office of the Director»NIH Office of Management»NIH Office of Logistics and Acquisition Operations (OLAO)

Read the full report